Location History:
- Pentling-Graβlfing, DE (2017)
- Pentling-Grasslfing, DE (2018)
- Rottenbuch, DE (2019)
Company Filing History:
2 out of 2 
1 out of 42 
1 out of 1 Years Active: 2017-2019
Title: Innovations and Contributions of Inventor Günter Sprotte
Introduction
Günter Sprotte is a notable inventor based in Rottenbuch, Germany. He has made significant contributions to the field of biomedical research, particularly in the development of predictive biomarkers and therapeutic agents. With a total of three patents to his name, Sprotte's work has the potential to impact clinical practices significantly.
Latest Patents
One of his latest patents focuses on predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment. This invention provides methods for predicting how patients will respond to such treatments by evaluating the expression of specific biomarkers. These biomarkers include CD14, CD68, TLR4, TLR7, IL6, IL8, IL10, IFN-alpha, IGF1, CXCL1, CXCL9, CXCL10, RAGE, GDNF, and BCHE, among others. Another significant patent involves the use of agents consisting of antibodies and/or insulin-like growth factor antagonists for treating or preventing certain diseases. This invention highlights the potential of various compositions, including antibodies and Toll-like receptor antagonists, in therapeutic applications.
Career Highlights
Throughout his career, Sprotte has worked with reputable organizations, including Ignova GmbH and Julius-Maximilians-Universität Würzburg. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Sprotte has collaborated with notable colleagues such as Ana Maria Waaga-Gasser and Jan Wesjohann. These partnerships have enriched his research and expanded the scope of his inventions.
Conclusion
Günter Sprotte's innovative work in the field of biomedical research showcases his dedication to improving clinical outcomes through scientific advancements. His patents reflect a commitment to developing effective treatments and predictive tools that can benefit patients in need.